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Since the 2006 European ban on the use of antibiotics as growth promoters in animal
feed, numerous studies have been published describing alternative strategies to prevent
diseases in animals. A particular focus has been on prevention of necrotic enteritis in
poultry caused by Clostridium perfringens by the use of microbes or microbe-derived
products. Microbes produce a plethora of molecules with antimicrobial properties and
they can also have beneficial effects through interactions with their host. Here we review
recent developments in novel preventive treatments against C. perfringens-induced
necrotic enteritis in broiler chickens that employ yeasts, bacteria and bacteriophages
or secondary metabolites and other microbial products in disease control.
Keywords: Clostridium perfringens, necrotic enteritis, broiler chicken, antimicrobials, probiotic, competitive
exclusion, bacteriocin
INTRODUCTION
Clostridium Perfringens, the Causative Agent for Necrotic
Enteritis
Clostridium perfringens is a spore-forming, anaerobic, Gram-positive bacterium, found in the
environment and also in the gastro-intestinal (GI) tract of humans and animals (Songer, 1996;
Van Immerseel et al., 2004; Popoff, 2013). It is one of the most common causes of foodborne
illnesses in humans, but it also poses an important threat for animals (Uzal et al., 2010; Grass et al.,
2013). Indeed,C. perfringens is responsible for severe infections in animals, such as enterotoxaemia,
gangrenous dermatitis and necrotic enteritis (NE), especially in pigs and poultry (Songer, 1996; Van
Immerseel et al., 2004; Timbermont et al., 2011).
C. perfringens strains can produce up to 17 different toxins (the majors toxins α, β, β2, ε, ι and
the enterotoxin CPE), recently reviewed by Uzal et al. (2014). C. perfringens isolates are classified in
5 toxinogroups, based on their toxin production (Songer, 1996; Van Immerseel et al., 2009), each
set of toxins being responsible for a specific disease (Uzal et al., 2010). For examples, type B strains,
which produce α, β, and ε toxins cause lamb dysentery and type D strains, which only produce the α
and ε toxins are responsible enterotoxaemia in those animals (Songer, 1996; Uzal et al., 2010, 2014;
Popoff, 2013). In poultry, necrotic enteritis is caused mainly by type A strains, which produce the α
toxin and the pore-forming toxin NetB (for NE B-like) (Engström et al., 2003; Keyburn et al., 2008;
Cooper and Songer, 2009). The α toxin was long thought to be responsible for necrotic enteritis
but several reports have since established that the NetB toxin alone can cause the disease (Keyburn
et al., 2008, 2010; Van Immerseel et al., 2009).
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Another notable mechanism contributing to the virulence of
C. perfringens is the production of bacteriocins. Virulent strains
of C. perfringens have been shown to inhibit the growth of
other C. perfringens strains in order to take advantage during
competition for nutrients (Barbara et al., 2008; Timbermont
et al., 2009). Recently, Timbermont and colleagues identified
perfrin, a novel 11.5 kDa bacteriocin that is produced by a NetB-
positive strain isolated from a chicken with NE. Intriguingly,
perfrin has no sequence homology to other bacteriocin proteins,
suggesting that this is the paradigm for a new class of bacteriocin
(Timbermont et al., 2014). It is likely that further bacteriocins
remain to be discovered.
Necrotic Enteritis and Broiler Chickens
C. perfringens-induced NE in chickens leads to sudden death,
with mortality rates up to 50% (Kaldhusdal and Løvland, 2000;
McDevitt et al., 2006; Lee et al., 2011b). More importantly,
C. perfringens is also responsible for subclinical infections,
associated with chronic damage of the intestinal mucosa. Such
subclinical infections cause problems such as lower performance
and reduced weight gain, which have dramatic economic
consequences (Elwinger et al., 1992; Kaldhusdal et al., 2001;
Skinner et al., 2010). The cost of NE worldwide was estimated to
2 billion dollars per year, which includes not only direct loss due
to broilers deaths, but also veterinary and cleaning costs (Van der
Sluis, 2000; Timbermont et al., 2011).
C. perfringens is almost always found in healthy chickens,
although at levels less than 105 cfu/g intestinal content. The
ability of the bacterium to cause disease is linked to several
predisposing factors that affect intestinal conditions and create
a favorable environment for proliferation. Perhaps the most
important of these factors is the incidence of coccidiosis (Al-
Sheikhly and Al-Saieg, 1980; Craven et al., 2001; Williams, 2005;
Si et al., 2007). NE incidence and the mortality rates are higher
when chickens are co-infected with Eimeria, a causal agent of
coccidiosis (Shane et al., 1985; Baba et al., 1992). The feeding diet
has been shown to be another factor favoring disease, through
an influence on the properties of the intestinal content such as
viscosity and the presence of non-digestible polysaccharides, the
GI tract transit time and the intestinal pH (Annett et al., 2002;
Drew et al., 2004; Moran, 2014). For example, diets rich in wheat
or fish proteins are known to increase the risk of necrotic enteritis
(Annett et al., 2002; Drew et al., 2004).
Animals are often infected through bacterial cells or spores
present in their feed, from contaminated litter or by cross-
contamination with infected animals at the early stages of life.
Young animals, which have immature immune systems and
no established commensal flora, are primarily at risk. Infected
animals show severe lesions of the jejunum and ileum, the small
intestine presenting a degenerated mucosa and being distended
by gases produced by C. perfringens. Signs of infection include
the animal looking depressed, moving less and having diarrhea,
which is the most visibly obvious symptom. For a more detailed
coverage of C. perfringens pathogenicity and clinical signs of NE,
the reader is directed to a number of other articles (Helmboldt
and Bryant, 1971; Van Immerseel et al., 2004; Timbermont et al.,
2011; Paiva and McElroy, 2014).
The rapid death (within 24 h) of chickens with NE often
prevents the treatment of the disease. Antibiotics have been
commonly used worldwide as growth promoters and for
prophylactic treatment of C. perfringens-induced NE in poultry.
However, with the European ban on antibiotics (feed additives
regulation 1831/2003/EC), which took effect in January 2006,
alternatives to antibiotics became essential in order to prevent
NE occurrence and the consequent economic losses for the
poultry industry. Preventive treatments can take the form of
actions on predisposing factors, such as coccidiosis prevention,
diet modifications, or improving overall cleanliness and hygiene.
Alternatively they can directly target the causal agent of
the disease by controlling the proliferation, colonization and
persistence of virulent strains of C. perfringens or interfering with
virulence and pathogenicity factors (Figure 1). C. perfringens
infections can be reduced or abolished by using natural feed
additives, such as probiotics (yeasts or bacteria), plants (Engberg
et al., 2012), molecules of plant origin [for example, essential oils
(Mitsch et al., 2004; Timbermont et al., 2010) or Annatto extracts
(Galindo-Cuspinera et al., 2003)], organic acids (Geier et al.,
2010; Timbermont et al., 2010), enzymes (Jackson et al., 2003;
Engberg et al., 2004), lysozyme (Liu et al., 2010), or molecules
of microbial origin, such as yeast extract and antimicrobial
peptides (Figure 1). Here we give an overview of these preventive
treatments, by focusing on micro-organisms and molecules or
products of microbial origins that affects C. perfringens growth
and pathogenicity.
FEEDING “LIVE” BACTERIA AND YEASTS
Supplementation of the broilers’ diet with one or several
beneficial bacteria has proven to be efficient to prevent
the overgrowth of pathogens and the subsequent diseases.
Several bacterial strains have been shown to increase broiler
chickens performance (health, weight gain, feed conversion)
and to prevent or reduce the incidence of diseases caused by
pathogenic bacteria (reviewed by Patterson and Burkholder,
2003; Lutful Kabir, 2009; Chaucheyras-Durand and Durand,
2010). Probiotics, or direct-fed microbials, and competitive
exclusion (CE) cultures are thus commonly used in broiler farms.
There are several commercially available products that have been
shown to be efficient against C. perfringens and NE in poultry
(Table 1).
Probiotics
A probiotic is defined as “a live microbial food supplement
that beneficially affects the host by improving the intestinal
microbial balance” (Fuller, 1999). Indeed, probiotics can interact
with the host to improve immunity and intestinal morphology
or stimulate the metabolism, thus reducing the risk of infection
by opportunistic pathogens. Probiotic bacteria have also been
shown to produce molecules with antimicrobial activities, such
as bacteriocins, that target specific pathogens, or even inhibit the
adhesion of pathogens or the production of pathogenic toxins
(Joerger, 2003; Pan and Yu, 2014). Moreover, beneficial bacteria
can act as competition against pathogenic strains within the
host. The concept of competitive exclusion will be discussed
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FIGURE 1 | Identification of C. perfringens virulence and pathogenicity factors as potential targets for NE prevention. C. perfringens virulence and
pathogenicity factors are represented as colored boxes. Antagonistic action of the microbes and microbe-derived products discussed in this review are represented
by flat-end arrows.
TABLE 1 | Examples of commercially available microbial feed additives for NE prevention in poultry.
Product Company Composition Origin Activity Selected references
Aviguard® MSD Animal Health Over 200 bacterial species Healthy, adult chickens Competitive exclusion Hofacre et al., 1998
BROILACT® Nimrod Veterinary
products
Complex mixture of bacteria Intestine of a normal adult fowl Competitive exclusion Kaldhusdal et al., 2001
PoultryStar® Biomin 6 bacterial species and 1
prebiotic (FOS)
Unknown Competitive exclusion McReynolds et al., 2009
MSC™ Continental Grain Co. Bacteria Caeca and caecal sections Competitive exclusion Craven et al., 1999
Finelact™ QTI Animal Health L. reuteri Live, healthy chicken Probiotic Tested in a field trial
(manufacturer’s product data)
FloraMax® B-11 Pacific Vet Group,
USA
11 lactic acid bacteria and
inactivated Saccharomyces
cerevisiae
Poultry intestine Probiotic Layton et al., 2013
NuPro® Alltech Inc. Yeast extract Yeast Immunostimulation,
antimicrobial activity
Thanissery et al., 2010
SafMannan® Phileo Lesaffre Animal
Care
Yeast Extract S. cerevisiae Immunostimulation,
antimicrobial activity
Abudabos and Yehia, 2013
further below. For the purpose of this section, we have chosen
to focus on strains that were shown to have an effect on NE
incidence in poultry, through a targeted antagonistic activity
against C. perfringens.
A large number of studies described the isolation of
microorganisms with anti-C. perfringens activity in vitro
(Table 2). Most of these strains belong to the genera Bacillus and
Lactobacillus. Very few reports discussed the deployment of live
yeasts with antagonistic activity againstC. perfringens, their use in
NE prevention being limited to inactivated yeast or yeast extract
(Tables 1, 2).
Yeasts
Despite being under-represented in the literature as anti-
C. perfringens agents, yeasts are known to have antimicrobial
properties, which were recently reviewed (Hatoum et al., 2012).
In addition the cell wall is, for many types of yeast, rich in beta-
glucans, which have immunomodulatory properties (Novak and
Vetvicka, 2008). On top of the beneficial effects they have on
the host, yeasts can constitute a protection against pathogens
by (i) producing mycocins, (ii) secreting enzymes that degrade
bacterial toxins, (iii) preventing adhesion to epithelial cells, or
(iv) by acting as a competitive exclusion agent (reviewed by
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TABLE 2 | Examples of probiotic strains with anti-C. perfringens activity in vitro and in vivo.
Strain Origin Anti-Cp activity Anti-Cp activity Mode of action References
in vitro in vivo (poultry model)
Bacillus
Bacillus cereus 8A n.s. + n.t. Bacteriocin Bizani and Brandelli, 2002
Bacillus licheniformis Broiler GI tract + n.t. n.s. Barbosa et al., 2005
n.s. n.t. + Spores Knap et al., 2010
B. pumilus Broiler GI tract + n.t. n.s. Barbosa et al., 2005
B. subtilis Broiler GI tract + n.t. n.s. Barbosa et al., 2005
Porcine intestine + n.t. Bacteriocin Klose et al., 2010
Healthy chicken GI tract + + Protein Teo and Tan, 2005; Jayaraman et al., 2013
n.s. − + Spores La Ragione and Woodward, 2003
Enterococci
E. faecium Porcine intestine + n.t. Lactate and H2O2 Klose et al., 2010
Fermented food + n.t. 3,000 Da BLIS Chen et al., 2007
Broiler GI tract + n.t. Enterocin A/B Shin et al., 2008
n.s. + n.s. Cao et al., 2013
E. faecalis Human + n.t. Bacteriocin Bottone et al., 1974
Human + n.t. n.s. Stark, 1960
n.s. −a + Toxin inhibition Fukata et al., 1991
E. durans Human + n.t. n.s. Stark, 1960
Bifidobacteria
B. animalis ssp lactis Commercial strain + n.t. NS molecule Schoster et al., 2013
B. infantis n.s. + n.t. n.s. Gibson and Wang, 1994
B. thermoacidophilum Porcine intestine + n.t. Lactate and H2O2 Kim et al., 2007; Klose et al., 2010
Lactobacilli
Lactobacillus sp. Chicken feces + + n.s. Gérard et al., 2008
L. acidophilus n.s. −a + Toxin inhibition Fukata et al., 1991
L. amylovorus Porcine intestine + n.t. Lactate and H2O2 Kim et al., 2007; Klose et al., 2010
L. animalis Dog feces + +b n.s. Biagi et al., 2007
L. fermentum Porcine epithelium + n.t. Toxin inhibition Allaart et al., 2011
Reference strain n.t. +c n.t. Cao et al., 2012
L. johnsonii FI9785 Poultry − + n.t. La Ragione et al., 2004
L. mucosae Porcine intestine + n.t. Lactate and H2O2 Klose et al., 2010
L. plantarum Commercial strain + n.t. BS molecule Schoster et al., 2013
L. reuteri Porcine intestine + n.t. Lactate and H2O2 Kim et al., 2007; Klose et al., 2010
L. salivarius Chicken intestine + n.t. Lactate and H2O2 Kim et al., 2007; Klose et al., 2010
aActive against toxin production.
bActive in a canine model.
cReduced inflammation.
n.s., not specified; n.t., not tested; BLIS, bacteriocin-like inhibitory substance; NS, narrow spectrum; BS, broad spectrum.
Hatoum et al., 2012). For example,Debaromyces hansenii secretes
molecules with anti-C. butyricum activity (Fatichenti et al., 1983),
and Saccharomyces boulardii secretes a serine protease that
inhibits the action of C. difficile toxins in vivo and in vitro
(Castagliuolo et al., 1996, 1999).
Field trials using live S. boulardii as feed additives
obtained positive results on performance and intestinal
health improvement in healthy chickens (Rajput et al., 2013)
and in chickens infected with Salmonella Enteritidis (Gil de
los santos et al., 2005). Moreover, another study by the same
authors showed that using a recombinant strain of Pichia pastoris
carrying the gene coding for the C. perfringens α toxin, not only
improved broiler chickens performance, but also increased the
secretion of anti-C. perfringens antibodies (Gil de los santos et al.,
2012). It would be interesting to test the effects of these strains on
the mortality and C. perfringens counts in C. perfringens-induced
NE challenged birds. It is also worth noting that two fungi of
the genus Fusarium were reported to produce mycocins with
anti-C. perfringens activity (enniatin B of F. tricinctum and
the beauvericin of F. proliferatum), which were active at low
concentrations (20µg/ml and 0.1µg/ml, respectively; Meca
et al., 2010, 2011).
Bacillus Species
Several strains of Bacillus have been shown to have antagonistic
activity against C. perfringens (Table 2). In most studies, the
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activity was linked to the production of bacteriocins. Indeed,
within the Bacillus genus, several species are known to produce
bacteriocins and antimicrobial peptides (Stein, 2005; Lee and
Kim, 2011; Mongkolthanaruk, 2012; Cochrane and Vederas,
2014). For example, B. thuringiensis produces thuricin which is
active against C. difficile (Rea et al., 2010).
The antagonistic species described in the literature include B.
cereus, B. licheniformis, B. pumilus, and B. subtilis, which was
the most represented. In a study involving over 200 Bacillus
strains isolated from broiler feces, Barbosa et al. (2005) identified
several species (licheniformis, pumilus, subtilis) with activity
against C. perfringens in vitro (Barbosa et al., 2005). A Bacillus
cereus strain, isolated from a soil sample in Brazil, also showed
antagonism against C. perfringens. The activity of the strain was
ascribed to the production of a bacteriocin during the exponential
phase of growth (Bizani and Brandelli, 2002). Teo and Tan
(2005) isolated B. subtilis strain SP6 and showed that it had anti-
C. perfringens activity in vitro (Teo and Tan, 2005). The authors
identified the molecule responsible for the antagonistic activity
as a 960–983 Damolecule of proteinacious nature that was highly
heat-stable (Teo and Tan, 2005). The same strain was used in aNE
challenge field trial involving 216 chicks and was shown to reduce
mortality by half, to improve intestinal health (as measured by
villi length) and to significantly reduce C. perfringens counts
(Jayaraman et al., 2013).
The supplementation of animal feed with Bacillus spores was
also tested and proven to be an efficient alternative to the use of
antibiotics.When 20 day old chicks, inoculated with low amounts
of C. perfringens, were given a single dose of 109 B. subtilis spores,
colonization and persistence of C. perfringens were abolished,
although the B. subtilis strain alone was shown to be unable to
affect C. perfringens in vitro (La Ragione and Woodward, 2003).
In another field trial, Knap et al. (2010) tested the effect of adding
B. licheniformis spores to the diet, but used larger amounts and
for longer periods of time (Knap et al., 2010). They observed
increased performance and reduced mortality in the group of
chicks treated with the spores.
Enterococci
A strain of E. faecium when fed to chicks on day of hatch was
shown to reduce numbers of C. perfringens along with other
pathogens after 28 days, and concomitantly to increase the counts
of lactic acid bacteria (Lactobacilli and Bifidobacteria) (Cao et al.,
2013). Klose et al. (2010) tested a number of Enterococcus strains,
isolated from various animals, for their antagonism against
C. perfringens and found that almost all had anti-C. perfringens
activity, which could be attributed to the production of acids and
hydrogen peroxide (Klose et al., 2010). Enterococci are known to
produce a wide-range of bacteriocins, called enterocins, which
are active against Gram-positive and Gram-negative bacteria
(Franz et al., 2007). Shin et al. (2008) isolated a strain of E. faecium
from broiler intestines that was active against C. perfringens in
vitro, and identified the antimicrobial molecules as enterocins,
with high homology to enterocins A and B (Shin et al., 2008).
Strains of E. faecalis were also active against C. perfringens in vivo
(Stark, 1960; Bottone et al., 1974; Fukata et al., 1991) (Table 2).
One strain even prevented C. perfringens proliferation in vivo
and inhibited α toxin production in vitro (Fukata et al., 1991).
However, the potentially pathogenic nature of E. faecalis could
prevent its use as a probiotic feed additive.
Lactic Acid Bacteria
Lactic acid bacteria (LAB) are also very good probiotic
candidates, as they display antimicrobial activities, but also
have beneficial effects for the host. Cao et al. (2012) showed
that adding L. fermentum I.2029 to the diet of young chicks
reduced the occurrence of C. perfringens-induced ileal lesions
and inflammation. However, the effect on C. perfringens numbers
was not measured in this study. Cao and colleagues also showed
that the addition of the probiotic stimulated the host immune
system, as seen by increased levels of cytokine expression,
measured by real-time PCR (Cao et al., 2012). Many LAB
isolates have exhibited anti-C. perfringens activity in vitro
(Table 2). For example, in a screening experiment involving
104 Lactobacillus strains isolated from geese feces, 84 strains
were active against C. perfringens (Dec et al., 2014). Related
to that, Kim et al. (2007) isolated several LAB (Lactobacillus
and Bifidobacterium) from pig intestines that had antagonistic
action against C. perfringens, with an L. amylovorus strain
presenting properties amenable to be a potential probiotic
candidate (Kim et al., 2007). The antimicrobial action of
LAB is often attributed to the secretion of bacteriocins or
the production of organic acids. Schoster et al. (2013) tested
the inhibitory activities of several commercial strains against
C. perfringens in vitro. These authors identified 2 LAB strains, L.
plantarum, and B. animalis spp. lactis, with antagonism against
reference strains, but also against clinical isolates (Schoster
et al., 2013). The L. plantarum strain was active against Gram
negative and Gram positive strains, whereas the Bifidobacterium
isolate had a narrower spectrum of activity (Schoster et al.,
2013).
The ability of a potential probiotic strain to survive in the
host without affecting the bacterial balance or the beneficial
flora is of major importance. In this regard, the in vitro studies
that report the isolation of potential probiotic strains almost
always test the strain for their ability to survive in the host
and exert their action in vivo, through assessment of acid and
bile resistance, auto-aggregation and adhesion to epithelial cells.
A strain of Lactobacillus species that reduced C. perfringens
numbers in chickens was shown not to affect the commensal
flora (Gérard et al., 2008). In a trial conducted by La Ragione
et al. (2004), 20 day old chicks were fed a strain of L. johnsonii
(FI9785). This strain was able persist in the chicks for the
duration of the experiment, caused a reduced colonization by
C. perfringens after 15 days, although no direct anti-C. perfringens
activity was evident in vitro (La Ragione et al., 2004). Layton and
colleagues tested the efficacy of the probiotic FloraMax-B11 (FM-
B11), which consists of several LAB strains (Table 1) on chicks
challenged with E. maxima, S. typhimurium and C. perfringens
(Layton et al., 2013). The chicks started receiving the probiotic
on day 14 and were infected 7 days later. After 10 days, they
observed a high reduction of mortality in the group treated with
FM-B11, along with reduced intestinal lesions and C. perfringens
counts. Furthermore, FM-B11 was shown to be active against
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C. perfringens in vitro (Layton et al., 2013). Allaart et al. (2011)
described an example of an antagonistic action that targeted
pathogenicity via the inhibition of toxin production. A probiotic
strain of L. fermentum of porcine origin negatively regulated the
production of the β2 toxin by C. perfringens, without affecting
cell growth (Allaart et al., 2011). The action of L. fermentum on
β2 toxin production appeared to occur at the transcription level
and was exerted through an effect on the environmental pH. The
exact mechanism is however still unclear and it is not known
whether the same effect would be observed in vivo (Allaart et al.,
2011).
Competitive Exclusion
The concept of competitive exclusion (CE) was originally
described by Nurmi and Rantala in 1973, when feeding young
chicks with bacteria isolated from a healthy adult chicken
prevented colonization by Salmonella infantis (Nurmi and
Rantala, 1973; Rantala and Nurmi, 1973). The exact mechanisms
of action of CE remain unclear. However, it is now well
known that implanting a “healthy” flora in the early days of
life accelerates the establishment of the intestinal flora and
creates a competition for nutrients within the intestine, thus
preventing colonization by pathogens (Joerger, 2003; Schneitz,
2005). Moreover, the beneficial effects can be due to the intrinsic
properties of the bacteria composing the mixture, as described
above in the “Probiotics” section. CE products were initially
described against Salmonella in chickens. Since then several
studies focusing on the effect of CE to prevent C. perfringens-
associated CE have been published, and several commercial
products with proven effects on C. perfringens-induced NE are
available (Table 1).
The first reports discussing the use of caecal contents from
healthy chickens to prevent NE in young chicks date from the
early 80 s. Barnes et al. (1980) described experiments in which
1-day-old chicks were fed caecal samples from healthy hens,
containing, among others, several Lactobacillus, Streptococcus
faecalis, S. faecium (now called Enterococcus faecalis and E.
faecium) and Bacteroides hypermegas (Barnes et al., 1980). After 3
days, they observed a reduction in the number of C. perfringens,
ranging from 100 to 1000 times lower in treated animals.
Since then, several reports have been published, reporting a
globally better intestinal health, a reduction in the number of
C. perfringens and lower mortality, after administration of a CE
product. The composition and efficacy of commercialized CE
cultures have been the focus of several studies (Table 1). Elwinger
and colleagues showed that the use of Broilact R© reduced the
mortality and occurrence of NE, with less C. perfringens in
the caecum of animals in the treated group (Elwinger et al.,
1992). Another field trial involving Broilact R© was performed by
Kaldhusdal et al. (2001) where chicks were sprayed with this
CE product on the day of hatch. They observed a reduction in
C. perfringens counts, lower incidence of NE and NE-associated
gut lesions, with a most significant effect observed in the early
weeks of life (Kaldhusdal et al., 2001). Another research group
tested the efficacy of MSC™ (for Mucosal Starter Culture) which
is another commercial product consisting of bacteria isolated
from the gut of a healthy chicken (Craven et al., 1999). They
used several virulent strains of C. perfringens to challenge the
animals and fed them MSC in their first 3 weeks of life;
interestingly, although they did not observe an effect on the
number of C. perfringens, they detected less enterotoxin in the
treated group compared to the control one, suggesting a selection
for less virulent C. perfringens strains. In another trial, they
additionally fed the birds a diet known to predispose them to
NE, which resulted in a reduction in toxins present and but also
in the numbers of C. perfringens (Craven et al., 1999). Hofacre
et al. (1998) performed a trial involving 900 chicks which were
challenged with C. perfringens and E. acervulina when 14 days
old. The chicks were treated with Aviguard R©, two other CE
products and one probiotic 3 days later. They observed reduced
mortality in the chickens treated with CE cultures compared
to the ones that only received the probiotic. Moreover, the
CE-treated animals had a reduction in lesions to the intestinal
mucosa and displayed overall increased feed conversion (Hofacre
et al., 1998). The same researchers later tested a different CE
product containing L. acidophilus, L. plantarum, E. faecium and
Pediococcus acidilactia (All-Lac XCL, Alltech) in combination
with a prebiotic (MOS, Alltech) and observed a reduction of
mortality by half compared to the untreated animals, with
effects comparable to those of bacitracin (Hofacre et al., 2003).
McReynolds et al. (2009) also tested the effects of CE cultures in
association with a prebiotic containing essential oils and fructo-
oligosaccharides (FOS) on chicks given an immunosuppressant
vaccine, inoculated with C. perfringens and in dietary conditions
favorable to NE development (McReynolds et al., 2009). Both
the prebiotic and the CE cultures led to reduced C. perfringens
counts, a reduction in the intestinal lesions and lower mortality
(McReynolds et al., 2009). Overall, the use of CE cultures in
combination with other products, probiotics and prebiotics that
have a more targeted action on C. perfringens appears to be more
effective to prevent NE occurrence in poultry.
MOLECULES OF MICROBIAL ORIGIN
Prebiotics
Prebiotics are additives that will stimulate the commensal flora
and enhance the beneficial effects of probiotics within the host
and are mostly indigestible oligosaccharides (Patel and Goyal,
2012). Numerous molecules have been described, with mannan-
oligosaccharides (MOS) being the main prebiotic of microbial
origin. MOS are components within the yeast cell wall and
constitute the main active ingredient of yeast extract (YE)
for disease control. They are often used as feed additives in
broiler diets (Table 1) where they have been shown to improve
intestinal health and immune response, and also inhibit pathogen
colonization by reducing adhesion. The addition of MOS to
broiler feed was shown to improve overall performance as
measured by productivity and weight gain (Fowler et al., 2015).
Thanissery and colleagues tested the effect of adding 2% yeast
extract (NuPro, Alltech) to broiler feed, for the first 10 days of life,
before a challenge with type A C. perfringens strains (Thanissery
et al., 2010). Overall, animals treated with NuPro had fewer
lesions in the duodenum compared to the untreated ones, to
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a degree comparable to the group treated with the antibiotic
bacitracin (Thanissery et al., 2010). The C. perfringens counts
were one to two logs lower in the treated groups; however, the
difference was not statistically significant; the authors suggested
the use of NuPro for longer periods in order to improve its
efficiency. Recently, Abudabos and Yehia (2013) tested another
commercial yeast extract additive, Saf-Mannan, in a field trial for
its ability to protect broiler chickens against NE (Abudabos and
Yehia, 2013). They performed a C. perfringens challenge on 16
days-old birds that were fed 0.05% Saf-Mannan since hatching,
and compared their performance, gut health and C. perfringens
counts on day 30. The chicks that were given the yeast extract
showed overall better intestinal health (based on villi height)
and had improved performance (measured by body weight
gain and feed conversion ratio), which are consistent with the
known beneficial effect of yeast extract on broiler performance.
Moreover, the animals treated with Saf-Mannan had a 5 log
reduction of C. perfringens numbers in the small intestine in
comparison to the untreated animals (Abudabos and Yehia,
2013). However, caution is required when discussing the anti-
C. perfringens of MOS or YE, as the antagonistic effect seems to
be highly variable and dependent on a number of variables, such
as dose, length of treatment or even diet (Biggs et al., 2007; Jacobs
and Parsons, 2009; Kim et al., 2011).
Bacteriocins
Bacteriocins are small ribosomally synthesized antimicrobial
peptides that are produced by a large number of bacteria. They
are classified based on their size, structure and post-translational
modifications (Cotter et al., 2013). One of the main benefits of
the use of bacteriocins is that some of them present a highly
specific antimicrobial activity, so that they can be used to treat
specific infections without altering the commensal gut flora. As
discussed previously, the action of many probiotic strains is
exerted through the secretion of bacteriocins (Table 2). Several
examples of well-described bacteriocins with beneficial effects
for broilers can be found. These include pediocin A, produced
by Pediococcus pentosaceus, and divercin of Carnobacterium
divergens, which were shown to improve broiler performance
in a field trial (Grilli et al., 2009; Józefiak et al., 2012) as well
as the well-characterized nisin produced by Lactococcus lactis
that was shown to affect C. perfringens cells and spores in vitro
(Udompijitkul et al., 2012). A strain of Ruminococcus gnavus,
isolated from an healthy human feces, was shown to produce
a 2.6 kDa bacteriocin (Ruminococcin A, class IIA lantibiotics)
that was highly active against C. perfringens in vitro (MIC
=75µg/ml) (Dabard et al., 2001). However, ruminococcin A
is poorly expressed in vivo as tested in R. gnavus-inoculated
rats, a potential limit on its usefulness (Crost et al., 2011). In
contrast, another bacteriocin (Ruminococcin C) identified by the
same research group, which was active against C. perfringens
with a MIC of 40µg/ml, was expressed in vivo (Crost et al.,
2011). Lee et al. (2011a) identified an anti-C. perfringens
lantibiotic produced by Bifidobacterium longum that had a
broad range of inhibition. Sharma and colleagues identified
a strain of Brevibacillus borstelensis with anti-C. perfringens
activity that was associated with a thermostable bacteriocin-like
inhibitory substance (BLIS) of 12 kDa, which was active under the
physiological conditions expected in the GI tract (Sharma et al.,
2014).
The use of purified bacteriocins or the producing strains as
feed additives represents a realistic alternative to conventional
antibiotics. Thorough characterizations are required, however, to
confirm the synthesis and the integrity of the molecule in GI tract
conditions. Moreover, the potential development of resistance in
the C. perfringens target organism needs to be taken into account.
BACTERIOPHAGES
Bacteriophages are highly species-specific viruses that infect and
kill bacteria. Upon replication within the bacterial cell, phages
produce endolysins, which target peptidoglycans and lyse the
bacterial cell wall, freeing the phages and allowing them to
spread to other cells (Nakonieczna et al., 2015). Phages were first
discovered and described a century ago (Twort, 1915; d’Hérelles,
1917). Phage therapy was widely used to treat bacterial infections
until the 40 s, and has seen a recent upsurge in interest with the
growing need for alternatives to antibiotic treatments to treat
diseases caused by antibiotic-resistant bacteria.
Many bacteriophages of C. perfringens have been described
and sequenced (Morales et al., 2012; Seal et al., 2012;
Volozhantsev et al., 2012), including several that were isolated
from strains of poultry origin and that had specific anti-
Clostridium activity (Zimmer et al., 2002a; Seal et al., 2011;
Volozhantsev et al., 2011; Seal, 2013). The use of bacteriophages
to limit C. perfringens infection has proven efficient in field trials.
For example, Miller et al. (2010) showed that feeding broilers
with a mixture of six bacteriophages reduced mortality in an
NE challenge by over 90% and improved overall performance
assessed as weight gain and feed conversion (Miller et al., 2010).
A number of studies focused on the use of bacteriophage
endolysins as antimicrobials, rather than the phage itself
(Zimmer et al., 2002b; Tillman et al., 2013; Gervasi et al.,
2014a; Swift et al., 2015). The use of phage proteins instead
of bacteriophages eliminates complications that can arise
with phage therapy. Indeed, several studies have described
bacteria becoming resistant to phage infection, by developing
mechanisms to prevent the entry of the phage in the cell
or by degrading the injected DNA (Nobrega et al., 2015). A
purified recombinant endolysin of bacteriophage φ3626, isolated
from a type strain of C. perfringens, was shown to have lytic
activity against over 40 strains of C. perfringens, without affecting
other Clostridium species or species of different genera, such
as Lactobacillus, Enterococcus or Bacillus (30 and 34 strains
tested respectively) (Zimmer et al., 2002a,b). Recently, a modified
endolysin was shown to be active against C. perfringens even
at high temperatures, making it a suitable candidate as an
antimicrobial additive for NE prevention (Swift et al., 2015).
Another research group characterized the endolysin CP25L,
isolated from a C. perfringens bacteriophage, which was active
against C. perfringens in vitro (Gervasi et al., 2013, 2014a). The
authors were able to over-express the enzyme in a modified
L. johnsonii strain, strain which was discussed earlier in this
review as active against C. perfringens in vivo (La Ragione et al.,
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2004; Gervasi et al., 2014a,b). This strain was able to survive
in GI tract-like conditions, but the expression of the endolysin
and the control of C. perfingens growth in co-culture were
inconsistent (Gervasi et al., 2014b). The use of probiotic strains
to deliver antagonist molecules within the GI tract is a promising
alternative; however, the application can be problematic. Indeed,
it is hard to predict the behavior of the molecule in vivo andmany
factors can interfere with its synthesis by affecting the producer
strain.
VACCINATION AGAINST C. PERFRINGENS
A large number of trials tested the efficacy of broiler vaccination
as a prophylactic treatment against C. perfringens-induced NE.
For the purpose of this review, we will limit this section to
an overview of the recent advances regarding vaccines against
C. perfringens. The reader is also directed to a recent review
by the Van Immerseel lab (Mot et al., 2014). Several strategies
have been used to vaccinate broilers against C. perfringens to
include use of live bacteria or inactivated toxins. Vaccines can
be delivered by spraying chicks upon hatching, by addition to
the feed or the drinking water, or even injected in ovo (Sharma,
1999; Muir et al., 2000; Mot et al., 2014). Vaccination using non-
virulent C. perfringens strains have proven to be inefficient, and
it has been shown that strains used in vaccines need to remain
mildly virulent. Thompson et al. (2006) showed that strains with a
mutation in the gene coding for the α toxin that were still virulent
(but less than the wild-type) were able to protect chickens against
NE, whereas an avirulent strain of C. perfringens did not have any
immunizing effects (Thompson et al., 2006).
Several trials have shown that chickens could be protected
against C. perfringens-induced NE by injection with inactive and
active toxins (Kulkarni et al., 2007; Jang et al., 2012) and antigenic
proteins (Jiang et al., 2009). Since the discovery of its role in
NE, the NetB toxin has been intensively studied with regards to
vaccination, with some promising results (Fernandes da Costa
et al., 2013; Keyburn et al., 2013a,b).
CONCLUSIONS AND PERSPECTIVES
A number of studies have now shown that the use of live
micro-organisms and molecules produced by microbes represent
potential alternatives to the use of conventional antibiotics for
the prevention of C. perfringens-induced NE in broiler chickens.
Although a large number of probiotic bacterial strains with
C. perfringens antagonism have been described, studies and trials
using live yeasts are surprisingly sparse and in our opinion
warrant further investigations. Antimicrobial molecules, such as
bacteriocins or phage endolysins, are also good candidates for
new antimicrobials. Research for new antimicrobials is, however,
limited by regulations and applicability andmainly focuses on the
use of GRAS micro-organisms, with restricted use of genetically
modified organisms (GMOs). Nanoparticles could also be used
as vectors for delivery of these new antimicrobial molecules, thus
avoiding the expression and regulatory issues that arise with the
use of live cells and GMOs.
It is difficult to identify a single “ideal” solution within this
wealth of options for NE disease control. Several microbes
and molecules of microbial origins, some already available
commercially, represent promising agents that conceivably
could be used in conjunction with one another to formulate
highly effective synergic antimicrobials. For example, a product
consisting of a CE culture, a probiotic strain producing a
targeted anti-C. perfringens molecule and a prebiotic product
would constitute a robust formulation that could prevent the
overgrowth of C. perfringens in vivo and maintain a healthy GI
tract flora at the same time.
Several criteria must be taken into account when developing
feed additives or preventive treatments for the animal industry.
The financial cost of the product is a major criterion, especially
for small animals with low market value, like broiler chickens.
A thorough genetic characterization of candidate strains is
essential in order to confirm the safety of the bacterial strain
and ensure the lack of virulence and antibiotic resistance genes.
The chosen molecule or strain must be able to stay active in
the host and withstand industrial treatments. One must also
keep in mind that the GI tract is a highly complex environment
with numerous bacterial species that can affect the efficacy
of these antimicrobials, perhaps in a different manner from
one animal to another. Moreover, C. perfringens and other
bacteria are highly adaptable micro-organisms. It is thus of
high importance to develop and use products in a rational
manner in order to avoid the appearance of strains resistant to
these novel antimicrobials, as has occurred with conventional
antibiotics.
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